Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Aerospace & Defense
Employment
Science
Infectious Disease
Freight & Air Courrier
Obesity, Weight Control & Nutrition
Gerontology
Oil & Gas
Computer Apps, Software & OS
Table bottom

Biotechnology
Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK...
PR Newswire, 10:13am ET



Venture capital (VC) investment in China reached a record high of over 40 billion U.S. dollars in 2017, up 15 percent year on year, an industrial report showed. The positive sentiment was driven by a number of mega deals as investors...
Xinhua, 9:33am ET

Face to face with the past came the audience at the Acropolis Museum in Athens on Friday evening when professor Manolis Papagrigorakis and his team unveiled the resurrected appearance of "Avgi" (Dawn), an 18-years old girl who lived around...
Xinhua, 8:38am ET

SmarTrend identified an Uptrend for Parexel Intl (NASDAQ:PRXL) on May 4th, 2017 at $67.53. In approximately 9 months, Parexel Intl has returned 30.44% as of today's recent price of $88.08. In the past 52 weeks, shares of Parexel Intl...
Comtex SmarTrend(R), 4:58am ET

SmarTrend identified a Downtrend for Five Prime Thera (NASDAQ:FPRX) on November 7th, 2017 at $30.30. In approximately 2 months, Five Prime Thera has returned 27.51% as of today's recent price of $21.96. Over the past year, Five Prime...
Comtex SmarTrend(R), 4:58am ET

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 2 weeks, Juno Therapeutic has returned 38.98% as of today's recent price of $67.81. Juno Therapeutic share prices have...
Comtex SmarTrend(R), 4:43am ET

Climate change caused by more carbon dioxide emissions leads to more flower blooms in tropical forest: study U.S. researchers have found that climate change resulting from more carbon dioxide emissions increases flower blooms in a...
Xinhua, 4:08am ET

1-7 of 7


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.